Search - tctmd.com

Displaying 421 - 440 of 654

Sort: Relevancy | Date

News Daily News

CAD Extent May Foreshadow Risk of Heart Failure After First MI

L.A. McKeown

March 31, 2016

News Daily News

AHA Issues Statement on Wearable Defibrillators, Cautions That Effectiveness Data Are Limited

Michael O'Riordan

March 31, 2016

News Daily News

Scoring System Simplifies Risk Assessment for Sudden Cardiac Death After NSTE ACS

L.A. McKeown

March 18, 2016

News Daily News

Study Fails to Support Routine PCI for Older Patients With Syncope and CAD

L.A. McKeown

March 07, 2016

News Daily News

Suboptimal Care for Women With CAD Linked to Higher Long-Term Mortality

Caitlin E. Cox

February 28, 2016

News Industry News

TherOx Enrolls First Patient in Study of Next-Generation Supersaturated Oxygen Therapy for AMI

February 17, 2016

News Daily News

Ticagrelor Loading Dose Provides Faster Platelet Inhibition Than Clopidogrel in Ad Hoc PCI

L.A. McKeown

February 09, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2016

Shelley Wood

February 01, 2016

News Daily News

In the Real World, Dabigatran and Warfarin Give Equal Stroke Protection to A-fib Patients

Todd Neale

January 25, 2016

News Daily News

Cath-Lab Complications: New Analysis Pinpoints Rate and Risks of Intraprocedural Thrombotic Events in ACS

Shelley Wood

January 21, 2016

News Daily News

PCI for Cardiogenic Shock: Mortality Has Increased, but So Has Patient Risk

Yael L. Maxwell

January 20, 2016

News Daily News

Early Invasive Intervention Trumps Delayed Approach in NSTEMI Patients

Michael O'Riordan

January 20, 2016

News Daily News

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

Yael L. Maxwell

January 05, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Daily News

早期数据显示抗血小板药物 PZ-128 效果可逆、起效快速，颇具前景

Caitlin E. Cox

December 20, 2015

News Daily News

Prometedores Primeros Datos para el Fármaco Antiplaquetario Reversible de Acción Rápida PZ-128

Caitlin E. Cox

December 20, 2015

News Daily News

Early Data Show Promise for Reversible, Fast-Acting, Antiplatelet Drug PZ-128

Caitlin E. Cox

December 20, 2015

News Daily News

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

Michael O'Riordan

December 15, 2015

News Daily News

CvLPRIT Substudy Finds Little Lasting Damage From Non-Infarct Artery PCI

Caitlin E. Cox

December 15, 2015

News Daily News

Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines

Yael L. Maxwell

December 14, 2015

Advertisement

CAD Extent May Foreshadow Risk of Heart Failure After First MI

AHA Issues Statement on Wearable Defibrillators, Cautions That Effectiveness Data Are Limited

Scoring System Simplifies Risk Assessment for Sudden Cardiac Death After NSTE ACS

Study Fails to Support Routine PCI for Older Patients With Syncope and CAD

Suboptimal Care for Women With CAD Linked to Higher Long-Term Mortality

TherOx Enrolls First Patient in Study of Next-Generation Supersaturated Oxygen Therapy for AMI

Ticagrelor Loading Dose Provides Faster Platelet Inhibition Than Clopidogrel in Ad Hoc PCI

TCTMD’s Top 10 Most Popular Stories for January 2016

In the Real World, Dabigatran and Warfarin Give Equal Stroke Protection to A-fib Patients

Cath-Lab Complications: New Analysis Pinpoints Rate and Risks of Intraprocedural Thrombotic Events in ACS

PCI for Cardiogenic Shock: Mortality Has Increased, but So Has Patient Risk

Early Invasive Intervention Trumps Delayed Approach in NSTEMI Patients

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

早期数据显示抗血小板药物 PZ-128 效果可逆、起效快速，颇具前景

Prometedores Primeros Datos para el Fármaco Antiplaquetario Reversible de Acción Rápida PZ-128

Early Data Show Promise for Reversible, Fast-Acting, Antiplatelet Drug PZ-128

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

CvLPRIT Substudy Finds Little Lasting Damage From Non-Infarct Artery PCI

Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content